Literature DB >> 11360204

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL.

C Belka1, B Schmid, P Marini, E Durand, J Rudner, H Faltin, M Bamberg, K Schulze-Osthoff, W Budach.   

Abstract

A combination of antitumor approaches acting on different death pathways seems ideal for increasing therapeutic responses, especially when defined resistance mechanisms interfere with individual cellular processes. Apoptosis pathways triggered by ionizing radiation (XRT) and the death ligand TRAIL were analysed in Jurkat lymphoma cells. Both induced the activation of caspase-8, caspase-3, BID and mitochondrial potential loss. TRAIL induced apoptosis required caspase-8, whereas it was not essential for radiation induced apoptosis. The inhibition of mitochondrial damage by Bcl-2 abrogated XRT induced apoptosis and caspase activation, but only marginally attenuated TRAIL induced cell death. The combined treatment with TRAIL and XRT exerted additive apoptotic effects in control cells, whereas highly synergistic effects occurred in cells overexpressing Bcl-2. In addition, a strong effect of TRAIL on radiation induced clonogenic cell death was found. In conclusion, TRAIL seems to be of high potential value for a combination with ionizing radiation in tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360204     DOI: 10.1038/sj.onc.1204318

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Molecular mechanisms of irradiation-induced apoptosis.

Authors:  Lei Zhou; Rong Yuan; Lanata Serggio
Journal:  Front Biosci       Date:  2003-01-01

2.  In vitro effects of topotecan and ionizing radiation on TRAIL/Apo2L-mediated apoptosis in malignant glioma.

Authors:  Emilio Ciusani; Danilo Croci; Maurizio Gelati; Chiara Calatozzolo; Francesca Sciacca; Luisa Fumagalli; Marco Balzarotti; Laura Fariselli; Amerigo Boiardi; Andrea Salmaggi
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Authors:  F Heinzelmann; W Bethge; D W Beelen; M Engelhard; N Kröger; P Dreger; D Niederwieser; J Finke; D Bunjes; J Tischer; G Kobbe; E Holler; M Bornhäuser; M Stelljes; H Baurmann; A Müller; I Haubitz; H Schrezenmeier; C Müller; H Ottinger
Journal:  Bone Marrow Transplant       Date:  2016-02-08       Impact factor: 5.483

4.  Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.

Authors:  Melinda S Merchant; James I Geller; Kristin Baird; Alexander J Chou; Susana Galli; Ava Charles; Martha Amaoko; Eunice H Rhee; Anita Price; Leonard H Wexler; Paul A Meyers; Brigitte C Widemann; Maria Tsokos; Crystal L Mackall
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

5.  Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.

Authors:  Patrizia Marini; Dorothea Junginger; Stefan Stickl; Wilfried Budach; Maximilian Niyazi; Claus Belka
Journal:  Radiat Oncol       Date:  2009-10-27       Impact factor: 3.481

6.  Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.

Authors:  John B Fiveash; G Yancey Gillespie; Patsy G Oliver; Tong Zhou; Michael L Belenky; Donald J Buchsbaum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-01       Impact factor: 7.038

7.  Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Authors:  Maximilian Niyazi; Patrizia Marini; Peter T Daniel; Robin Humphreys; Verena Jendrossek; Claus Belka
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

8.  Targeting apoptosis signaling pathways for anticancer therapy.

Authors:  Simone Fulda
Journal:  Front Oncol       Date:  2011-08-27       Impact factor: 6.244

9.  The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro.

Authors:  Amelie Rübel; René Handrick; Lars H Lindner; Matthias Steiger; Hansjörg Eibl; Wilfried Budach; Claus Belka; Verena Jendrossek
Journal:  Radiat Oncol       Date:  2006-03-29       Impact factor: 3.481

10.  Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis.

Authors:  Patrizia Marini; Angelika Schmid; Verena Jendrossek; Heidrun Faltin; Peter T Daniel; Wilfried Budach; Claus Belka
Journal:  BMC Cancer       Date:  2005-01-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.